Caveolin-1 deficiency alleviates MCD-induced hepatic steatosis by coordinating ACC inhibitory phosphorylation, cholesterol redistribution and inflammatory remodeling

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by progressive metabolic dysfunction accompanied by persistent hepatic inflammation. Increasing evidence implicates Caveolin-1 (Cav-1) in metabolic diseases; ho…

Error: (0)